Cancer drug prices: 30% trade margin cap on 137 medicines kicks in from November 9; activists say it doesn't go far enough
The NPPA found average trade mark-ups of about 170% on non-scheduled anti-cancer drugs, rising to 700% in some cases. The All India Drug Action Network says manufacturer prices remain untouched.
